The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (20): 2949-2953.doi: 10.3969/j.issn.1006-5725.2024.20.021

• Reviews • Previous Articles     Next Articles

Research progress of matrix metalloproteinase⁃28 in pulmonary disease

Ling TAN1,Xue MA2,Jingjing WANG3,Fengfeng LEI1,4()   

  1. The First Clinical Medical College of Lanzhou University,Lanzhou 730000,Gansu,China
  • Received:2023-12-17 Online:2024-10-25 Published:2024-11-05
  • Contact: Fengfeng LEI E-mail:leifengfenglf@163.com

Abstract:

Matrix metalloproteinase-28 (MMP-28) is widely expressed in vertebrates and plays diverse biological roles, participating in the regulation of various pathophysiological processes in the body. Increased expression of MMP-28 has been observed in chronic obstructive pulmonary disease, pulmonary fibrosis, and other lung diseases. Studies have demonstrated that MMP-28 promotes chronic inflammation and tissue remodeling by regulating macrophage recruitment and M2 polarization, and is involved in the pathogenesis of lung diseases by promoting cell proliferation and epithelial-mesenchymal transition. This article provides a review of the relationship between the basic characteristics of MMP-28 and pulmonary diseases.

Key words: matrix metalloproteinase-28, pulmonary disease, regulatory mechanism

CLC Number: